Pressor effect of NG-nitro-L-arginine in pentobarbital-anesthetized rats
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 47 (24) , 2217-2224
- https://doi.org/10.1016/0024-3205(90)90152-h
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Nω-Nitro-L-arginine: a potent inhibitor of the L-arginine-dependent soluble guanylate cyclase activation pathway in LLC-PK1 cellsCanadian Journal of Physiology and Pharmacology, 1990
- Control of regional blood flow by endothelium-derived nitric oxide.Hypertension, 1990
- l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitroBritish Journal of Pharmacology, 1990
- Nω-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formationEuropean Journal of Pharmacology, 1990
- Nitroarginine inhibits endothelium-derived relaxation.The Japanese Journal of Pharmacology, 1990
- Amino acids dilate resistance blood vessels of the perfused rat mesenteryJournal of Pharmacy and Pharmacology, 1989
- NG-methylarginine, and inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: Does nitric oxide regulate blood pressure in vivo?Biochemical and Biophysical Research Communications, 1989
- L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980